Why track with Glapp
To view or add a comment, sign in Today in #Employer Coverage: CMS has indefinitely postponed its BALANCE program that would have subsidized #GLP-1 obesity medications for Medicare members, a predictable outcome given the adverse selection risks and short-term cost challenges that make coverage financially untenable for health plans even at negotiated prices
Another meta-analysis of 21 RCTs involving 25,957 patients with T2DM, obesity, or overweight showed that semaglutide was associated with a lower risk of AF occurrence [29]
That is the difference good documentation makes
If someone does not know how much THC is in one gummy, they are already guessing
Clin Exp Immunol 204:296309 Cho HR, Uhm YK, Kim HJ, Ban JY, Chung JH, Yim SV, Choi BK, Lee MH (2011) Glutathione S-transferase M1 (GSTM1) polymorphism is associated with atopic dermatitis susceptibility in a Korean population